S.M.A.R.T. CONTROL Nitinol Stent System
Cordis US Corporation · Decision date Oct 15, 2026
What did the FDA decide?
FDA records P020036/S061 as a supplement to PMA P020036, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Oct 15, 2026.
FDA approval order statement
approval for an alternate supplier of a Bismuth Sub Carbonate Blend used in the catheter outer member
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 15, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P020036/S061
- Regulatory pathway
- PMA supplement
- Applicant
- Cordis US Corporation
- Product code
- NIO
- Decision code
- OK30
- Decision date
- Oct 15, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: STENT, ILIAC.
- Applicant
- Cordis US Corporation
- Product code
- NIO
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P020036. Subsequent supplements may change the device or its indications.
FDA decision timeline
P020036 · Original PMA
S.M.A.R.T. AND S.M.A.R.T. CONTROL NITINOL STENT SYSTEM
P020036/S061 received
Application receipt date recorded by FDA.
P020036/S061 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P020036. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P020036
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Cordis US Corporation | PMA approval | Aug 12, 2003 | FDA |
Explore the linked device profile
Other records with product code NIO
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Cook Ireland, Ltd. | PMA supplement | Nov 6, 2026 | FDA | |
| Medtronic Vascular, Inc. | PMA supplement | Oct 16, 2026 | FDA | |
| Biotronik AG | PMA supplement | Sep 11, 2026 | FDA | |
| Biotronik AG | PMA approval | Dec 17, 2015 | FDA | |
ZILVER VASCULAR STENTP050017 | Cook Ireland, Ltd. | PMA approval | Jun 26, 2006 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Cordis US Corporation
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 14201 NW 60th Ave., Miami Lakes, FL, 33014
Sources and methodology
- Original FDA record: P020036/S061
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



